CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −11,783 | $55.52 | $654K | 457,662 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −4,415 | $55.93 | $247K | 453,247 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −756 | $55.52 | $42K | 133,459 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −244 | $55.96 | $14K | 133,215 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −622 | $55.54 | $35K | 133,593 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −378 | $55.91 | $21K | 133,215 |
| 2026-07-27 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −16,198 | 137,000 | ||
| 2026-07-16 | Markels John Director | Grant or award · Stock Option (right to buy) | +23,029 | 23,029 | ||
| 2026-07-06 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +10,000 | $5.35 | $54K | 114,395 |
| 2026-07-06 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −7,913 | $57.16 | $452K | 106,482 |
| 2026-07-06 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −2,087 | $57.76 | $121K | 104,395 |
| 2026-07-06 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 226,827 | ||
| 2026-07-01 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +516 | $5.35 | $3K | 159,010 |
| 2026-07-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −1,788 | $56.03 | $100K | 157,222 |
| 2026-07-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −456 | $57.47 | $26K | 156,766 |
| 2026-07-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −6 | $57.82 | $347 | 156,760 |
| 2026-07-01 | Wassil Jim CHIEF OPERATING OFFICER | Option exercise · Stock Option (right to buy) 10b5-1 | −516 | 71,148 | ||
| 2026-06-26 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,683 | $54.28 | $363K | 468,020 |
| 2026-06-26 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −9,137 | $55.27 | $505K | 458,883 |
| 2026-06-26 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −6,417 | $56.12 | $360K | 452,466 |
Page 4 of 17 · 324 trades